NXLEarnings

Nexalin Technology Announces Fourth Peer-Reviewed Publication in Alzheimer’s Disease: 15 mA DIFS™ Significantly Improves Sleep Quality in Patients with Mild Alzheimer’s Disease

27, 2026 (GLOBE NEWSWIRE) — Nexalin Technology, Inc.

Published October 27, 2026 at 9:09 AM EDTNexalin Technology, Inc.Investor relations

Share this story

What matters

27, 2026 (GLOBE NEWSWIRE) — Nexalin Technology, Inc.

Primary source

TickerStar generated this brief from an official company, investor-relations, earnings-call, or regulatory source. Review the primary material before making an investment decision.

Open Investor relations

All NXL coverage

AAPLEarnings

Apple reports fourth quarter results

SBRAEarnings

SBRA Q3 2026 Normalized AFFO per diluted common share $0.41, Beat Guidance by +$0.01

PLTREarnings

Palantir Technologies Inc. 8-K Filing

BWXTEarnings

BWXT Q3 2026 Non-GAAP EPS $1.26, Beat Guidance by N/A - no Q3-only guidance provided

Follow NXL in real time

Get material earnings, filing, IR, and earnings-call alerts by email.

Create a free alert